Tumour hypoxia is linked to increased invasiveness, metastasis and treatment resistance in many cancers. However, how hypoxia influences expression of drug‑metabolising enzymes, including members of the aldehyde dehydrogenase (ALDH) family, is not fully understood. This study examined whether exposure to severe hypoxia alters expression of selected ALDH isoforms in colorectal cancer (CRC) cells and whether changes in expression influence redox balance and cell proliferation.
The investigators used four CRC cell lines: HT29, DLD‑1, SW480 and HCT116. Cells were cultured under standard (normoxic) conditions and severe hypoxia (0.1% O2). HT29 and DLD‑1 cells were also grown as multicellular spheroids (MCS) to model intratumour hypoxic regions. Expression of seven ALDH isoforms — ALDH1A1, ALDH1A2, ALDH1A3, ALDH1B1, ALDH2, ALDH3A1 and ALDH7A1 — was measured at the mRNA and protein levels. Functional experiments included siRNA knockdown of ALDH1A1, ALDH3A1 and ALDH7A1, measurement of reactive oxygen species (ROS) after perturbation, and stable overexpression of ALDH7A1 in a heterologous cell line (H1299).
Among the isoforms assessed, ALDH7A1 was consistently upregulated at both transcript and protein levels in HT29 and DLD‑1 cells exposed to 0.1% O2. The observation was reproducible across these two CRC lines, whereas the abstract does not report consistent hypoxia‑driven upregulation for the other ALDH isoforms tested. The data identify ALDH7A1 as a hypoxia‑responsive ALDH family member in the CRC models evaluated.
Elevated ALDH7A1 expression was detected in hypoxic regions of multicellular spheroids derived from HT29 and DLD‑1 cells, supporting the relevance of the finding in three‑dimensional models that develop oxygen gradients. Increased ALDH7A1 immunoreactivity was also observed in hypoxic zones of multiple CRC xenografts, including HT29, DLD‑1, HCT116, SW620 and COLO205, indicating that hypoxia‑associated ALDH7A1 expression occurs in vivo across several CRC tumour models.
siRNA‑mediated knockdown of ALDH7A1 in DLD‑1 cells produced several effects: reduced cellular proliferation, increased expression of ALDH3A1, and a significant elevation in intracellular ROS levels. These results suggest that ALDH7A1 contributes to redox homeostasis in these CRC cells and that loss of ALDH7A1 can trigger compensatory changes in other ALDH isoforms, indicating functional crosstalk within the family.
Complementary evidence came from stable overexpression experiments: H1299 cells engineered to overexpress ALDH7A1 displayed markedly reduced ROS levels compared with controls. This supports the hypothesis that ALDH7A1 activity can lower intracellular oxidative stress in cancer cells.
The combined observations — hypoxia‑driven ALDH7A1 upregulation in CRC cell lines and xenografts, increased ROS and reduced proliferation after ALDH7A1 knockdown, and ROS reduction with ALDH7A1 overexpression — support a role for ALDH7A1 in promoting adaptation to oxidative stress within the hypoxic tumour microenvironment. By contributing to redox balance, ALDH7A1 may help CRC cells survive in hypoxic niches, with potential implications for tumour progression and resistance to therapies that generate ROS.
The article title indicates a HIF‑1‑independent mechanism for hypoxia‑induced ALDH7A1 expression. However, the abstract and the provided text do not detail the experimental evidence or pathway analyses that demonstrate independence from HIF‑1, nor do they report the specific signalling intermediates responsible for ALDH7A1 induction. Similarly, quantitative data, statistical measures, and experimental conditions beyond oxygen tension and model systems (for example, time courses, fold‑change values, or measures of DNA damage) are not reported in the abstract provided. Therefore, readers should consult the full manuscript for detailed methods, quantitative results and mechanistic experiments that clarify the HIF‑1 independence claim.
This study identifies ALDH7A1 as a hypoxia‑responsive aldehyde dehydrogenase in colorectal cancer models. Upregulation of ALDH7A1 in hypoxic regions of spheroids and xenografts, together with functional data showing effects on proliferation and ROS, supports a role for ALDH7A1 in redox homeostasis and adaptation to tumour hypoxia. Specific mechanistic details and direct evidence excluding HIF‑1 involvement were not reported in the source abstract and require reference to the full report.